The Global Artificial Pancreas Device System (APDS) Market was valued at US$ 64.0 million in 2015 and is projected to expand at a CAGR of 18.6 % during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Growing demand for continuous diabetes monitoring and minimally invasive drug delivery system is expected to fuel growth of the artificial pancreas device system (APDS) market.
Type 1 diabetes patients require multiple doses of insulin through the day in order to manage their diabetes condition. Considering the current lack of feasible alternative solution to manage type 1 diabetes apart from administering insulin, an artificial pancreas that offers convenience with continuous management of glucose level in the body is the next best solution. An artificial pancreas system works 24 hours to automatically monitor and administer insulin in controlled amounts as per variations in glucose levels in the body. Medtronic’s MiniMed 620G and 640G were the first such devices launched in the global artificial pancreas device system (APDS) market in 2014 and 2015, respectively. Artificial pancreas system would ease the life of type 1 diabetic patients by eliminating the need for regular check on glucose level and administering insulin using injectors or pens.
To know the latest trends and insights prevalent in the artificial pancreas device system (APDS) market, click the link below:
Market players are majorly investing in research activities for development of artificial pancreas system in order to introduce novel treatment option in the market. For instance, Bigfoot Medical, Tandem Diabetes Care, Inc., and Beta Bionics are conducting clinical trials on artificial pancreas systems. The products are expected to be launched before 2020, which is expected to drive growth of the market. Furthermore, Medtronic’s 640G, Medtrum’s P6 Easy Touch Disposable Pump marketed in Europe is a semi-closed loop artificial pancreas that has 9% mean absolute relative difference (MARD), better than Freestyle Libre (11.4% MARD)
The closed loop system is majorly used for treatment of patients suffering from type 1 diabetes. Although. FDA has approved a hybrid model of an artificial pancreas, wherein the patient needs to adjust insulin intake during mealtime, an automated system would be a breakthrough innovation in the global artificial pancreas device system (APDS) market. Moreover, studies for bi-hormonal control system are in progress, which would enable controlling both hypoglycemic and hyperglycemic conditions. A bi-hormonal control system consists of dual-chamber pump, one containing insulin and the other containing counteracting hormone, glucagon.
According to the industry and Center for Diseases Control and Prevention (CDC) estimates, type 1 diabetes population accounts for nearly 5% of the total diabetic population. According to Juvenile Diabetes Research Foundation (JDRF), around 1.5 million type 1 diabetic patients were reported worldwide in 2015. The CDC estimates that more than 13,000 young people are diagnosed with type 1 diabetes annually in the U.S. Increasing number of population base along with the quest for developing an innovative diabetes monitoring and management therapy is projected to drive growth of the global artificial pancreas device system (APDS) market.
Key takeaways of the market:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.